
Italy · Biotechnology startup
CoStim Pharmaceuticals Inc.
Funding reportedLast round: Series A
Follow CoStim Pharmaceuticals and see its new rounds in your feed.Start following
CoStim Pharmaceuticals Inc.
operates as a biotechnology company. It develops antibody agents for treatment of cancer. The company was
Funding, as reported
Add your raise, your deck and your story, and put CoStim Pharmaceuticals in front of investors. Or tell us what we have wrong.